1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AGPAT4 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA TERF1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA NOVA1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA RENBP CTRPv2 pan-cancer AAC -0.12 0.001
mRNA LRRC8C CTRPv2 pan-cancer AAC 0.11 0.001
mRNA TATDN2 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ANAPC11 CTRPv2 pan-cancer AAC -0.11 0.001
mRNA KCNH7 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SLC7A14 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA PURG CTRPv2 pan-cancer AAC 0.12 0.001
Download CSV